Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Systematic review: medical therapy for fibrostenosing Crohn's disease.
Lu C, Baraty B, Lee Robertson H, Filyk A, Shen H, Fung T, Novak K, Ma C, Panaccione R, Achkar JP, El Ouali S, Bruining D, Jairath V, Feagan B, Rieder F; Stenosis Therapy and Research (STAR) Consortium. Lu C, et al. Among authors: baraty b. Aliment Pharmacol Ther. 2020 Jun;51(12):1233-1246. doi: 10.1111/apt.15750. Epub 2020 May 13. Aliment Pharmacol Ther. 2020. PMID: 32406116 Free PMC article.
Safety of drugs used for the treatment of Crohn's disease.
Pudipeddi A, Kariyawasam V, Haifer C, Baraty B, Paramsothy S, Leong RW. Pudipeddi A, et al. Among authors: baraty b. Expert Opin Drug Saf. 2019 May;18(5):357-367. doi: 10.1080/14740338.2019.1612874. Epub 2019 May 6. Expert Opin Drug Saf. 2019. PMID: 31026401 Review.
A Global Survey of Gastroenterologists' Travel Advice to Patients with Inflammatory Bowel Disease on Immunosuppressive Agents and Management of Those Visiting Tuberculosis-Endemic Areas.
Chan W, Shim HH, Ng SC; Asia–Pacific Crohn’s and Colitis Epidemiologic Study (ACCESS) Study Group; Liu J, Inglis C, Greveson K, Baraty B, Haifer C, Leong RWL. Chan W, et al. Among authors: baraty b. J Crohns Colitis. 2018 Nov 15;12(11):1261-1269. doi: 10.1093/ecco-jcc/jjy110. J Crohns Colitis. 2018. PMID: 30215692
Entyvio lengthen dose-interval study: lengthening vedolizumab dose interval and the risk of clinical relapse in inflammatory bowel disease.
Chan W, Lynch N, Bampton P, Chang J, Chung A, Florin T, Hetzel DJ, Jakobovits S, Moore G, Pavli P, Radford-Smith G, Thin L, Baraty B, Haifer C, Yau Y, Leong RWL. Chan W, et al. Among authors: baraty b. Eur J Gastroenterol Hepatol. 2018 Jul;30(7):735-740. doi: 10.1097/MEG.0000000000001150. Eur J Gastroenterol Hepatol. 2018. PMID: 29727386
Determining efficacy of dynamic multimedia bowel preparation instructions versus standard instructions on adenoma detection and patient reported measures (DIGICLEAN trial): a study protocol for a multicentre, colonoscopist-blinded, randomised controlled trial.
Au M, Low P, Rennie M, Mohseni M, Song Y, Kim N, Baraty B, Mitrev N, He E, Ho V, Leong R, Kariyawasam V. Au M, et al. Among authors: baraty b. BMJ Open. 2023 Jul 21;13(7):e073843. doi: 10.1136/bmjopen-2023-073843. BMJ Open. 2023. PMID: 37479508 Free PMC article.
Instituting surveillance guidelines and adverse outcomes in preeclampsia.
Menzies J, Magee LA, Li J, MacNab YC, Yin R, Stuart H, Baraty B, Lam E, Hamilton T, Lee SK, von Dadelszen P; Preeclampsia Integrated Estimate of RiSk (PIERS) Study Group. Menzies J, et al. Among authors: baraty b. Obstet Gynecol. 2007 Jul;110(1):121-7. doi: 10.1097/01.AOG.0000266977.26311.f0. Obstet Gynecol. 2007. PMID: 17601906